Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Catherine Vaczy Insider Profile
4 Followers
Catherine Vaczy, General Counsel at Lisata Therapeutics, holds 265.00K shares in Genprex (Ticker: GNPX), holds 71.23K shares in Lisata Therapeutics (Ticker: LSTA). Most recently, Catherine Vaczy Bought ― shares of Genprex on Apr 24, 2023 for an estimated value of 21.40K.
Catherine Vaczy has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Catherine Vaczy holds in companies
Most Profitable Insider Trade
The most profitable trade made by Catherine Vaczy
Catherine Vaczy's Trading History
Lisata Therapeutics
Apr 14, 2015
General Counsel
Uninformative Buy
―
$244.33K
Genprex
Apr 24, 2023
EVP GC Chief Strategy Officer
Informative Buy
21.40K
$511.45K
List of latest transactions for each holding click on a transaction to see Catherine Vaczy's performance on stock
You May Also Like
Catherine Vaczy insider profile FAQ
What is the percentage of profitable transactions made by Catherine Vaczy?
The percentage of profitable transactions made by Catherine Vaczy is ―.
What is the average return per transaction made by Catherine Vaczy?
The average return per transaction made by Catherine Vaczy is ―.
What stocks does Catherine Vaczy hold?
Catherine Vaczy holds: LSTA, GNPX stocks.
What was Catherine Vaczy’s latest transaction?
Catherine Vaczy latest transaction was an Informative Buy of $21.40K.
What was Catherine Vaczy's most profitable transaction?
Catherine Vaczy’s most profitable transaction was an Informative Buy of GNPX stock on April 24, 2023. The return on the trade was -93.80%.
What is Catherine Vaczy's role in Lisata Therapeutics?
Catherine Vaczy's role in Lisata Therapeutics is General Counsel.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.